Trail Ridge Investment Advisors LLC purchased a new stake in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 5,426 shares of the company’s stock, valued at approximately $697,000.
Several other institutional investors and hedge funds have also modified their holdings of MKGAF. Frazier Financial Advisors LLC acquired a new position in Merck KGaA during the second quarter worth $25,000. Rakuten Securities Inc. bought a new position in Merck KGaA during the second quarter valued at about $27,000. Solstein Capital LLC acquired a new stake in shares of Merck KGaA in the second quarter worth about $33,000. Burk Holdings LLC bought a new stake in shares of Merck KGaA during the 2nd quarter worth about $39,000. Finally, Bard Associates Inc. bought a new stake in shares of Merck KGaA during the 2nd quarter worth about $60,000. Institutional investors and hedge funds own 0.10% of the company’s stock.
Merck KGaA Stock Performance
Shares of OTCMKTS MKGAF opened at $163.45 on Tuesday. The business’s 50-day simple moving average is $162.78 and its 200-day simple moving average is $148.59. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31. Merck KGaA has a 52 week low of $116.68 and a 52 week high of $175.56. The firm has a market cap of $21.12 billion, a price-to-earnings ratio of 24.95 and a beta of 0.96.
About Merck KGaA
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Stories
- Five stocks we like better than Merck KGaA
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
